ArticleFoods (Basel, Switzerland)2026
Anti-Obesity Effects of Soy Peptides In Vivo: A Meta-Analysis of Randomized Controlled Trials.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Soybean peptides have been implicated in reducing body weight (BW); however, their efficacy for weight loss remains ambiguous. This study aimed to evaluate the effects of soybean peptides on BW outcomes via meta-analysis. To identify randomized controlled trials (RCTs) from January 2000 to June 2025, numerous databases (PubMed, Embase, Web of Science, and Cochrane Library) were searched comprehensively. Studies comparing the impact of different soybean peptide interventions on weight reduction were included. The weighted mean difference (WMD) and 95% confidence interval (CI) were synthesized. Surface under the cumulative ranking curve (SUCRA) determined the intervention rankings, and 18 RCTs met the inclusion criteria. Overall, soybean peptides significantly decreased BW (WMD = -1.96 g, 95% CI: -3.52, -0.40;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.